December 17, 2018
Precision Medicine Group Acquires Stern Investor Relations, Inc.Read more...
December 3, 2018
Clinical Omics - Unlocking the Value of Complex Biomarker DataDiscover more...
October 16, 2018
Precision for Medicine Acquires Liquid Biopsy and Tissue Profiling Pioneer ApoCellGet the story...
Precision for Medicine can help you find and extract the long-term value of innovative drugs
We develop your assays and manage global logistics, speeding to actionable answers. We use biomarkers to stratify patients, incomparably improving your R&D efficiency and success. We manage every aspect of your clinical trials from sites to biomarkers to diagnostics, all under a single roof. And we’re constantly adding services and expertise under that roof to support medical innovators — like our recent acquisition of ETHOS Health Communications, specializing in the interpretation and communication of medical science. In short: Precision dramatically accelerates your pathway from proof of concept to drug approval.
Choosing the Right Partner: Special Sample Needs For In Vitro Diagnostics
Barriers to Progress: Why Personalized Medicine Hasn't Developed for Chronic Conditions
6 Critical Factors for Achieving Approval of Oncology Drugs
In this high-stakes, high-velocity environment of oncology drug development and... Discover more »